Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates

Alzheimer’s disease (AD), the most prevalent form of dementia, remains incurable mainly due to our failings in the search for effective pharmacological strategies. Here, we describe the development of targeted multimodal polypeptide-based nanoconjugates as potential AD treatments. Treatment with pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Duro-Castano, A., Borrás, C., Herranz-Pérez, V., Blanco-Gandía, M. C., Conejos-Sánchez, I., Armiñán, A., Mas-Bargues, C., Inglés, M., Miñarro, J., Rodríguez-Arias, M., García-Verdugo, J. M., Viña, J., Vicent, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997513/
https://www.ncbi.nlm.nih.gov/pubmed/33771874
http://dx.doi.org/10.1126/sciadv.abf9180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997513/
https://www.ncbi.nlm.nih.gov/pubmed/33771874
http://dx.doi.org/10.1126/sciadv.abf9180

Ejemplares similares